Business Description
Chandra Bhagat Pharma Ltd
ISIN : INE07QQ01016
Share Class Description:
BOM:542934: Ordinary SharesTotal Employee Number:
40Compare
Compare
Traded in other countries / regions
542934.India IPO Date
2020-02-14Description
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | 2.29 | |||||
Interest Coverage | 1.38 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.06 | |||||
Beneish M-Score | -1.16 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.9 | |||||
3-Year EBITDA Growth Rate | 27.9 | |||||
3-Year EPS without NRI Growth Rate | 27.3 | |||||
3-Year FCF Growth Rate | 19.3 | |||||
3-Year Book Growth Rate | 6.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 72.66 | |||||
9-Day RSI | 58.92 | |||||
14-Day RSI | 52.01 | |||||
3-1 Month Momentum % | 29.39 | |||||
6-1 Month Momentum % | 1.43 | |||||
12-1 Month Momentum % | -22.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.5 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 11.32 | |||||
Days Sales Outstanding | 126.23 | |||||
Days Payable | 55.58 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.53 | |||||
Operating Margin % | 2.37 | |||||
Net Margin % | 2.62 | |||||
EBITDA Margin % | 6.2 | |||||
FCF Margin % | 7.15 | |||||
OCF Margin % | 7.94 | |||||
ROE % | 9.77 | |||||
ROA % | 3.22 | |||||
ROIC % | 2.63 | |||||
3-Year ROIIC % | -15.3 | |||||
ROC (Joel Greenblatt) % | 27.33 | |||||
ROCE % | 18.47 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 8.94 | |||||
PE Ratio without NRI | 8.94 | |||||
Shiller PE Ratio | 20.35 | |||||
Price-to-Owner-Earnings | 4.01 | |||||
PEG Ratio | 0.92 | |||||
PS Ratio | 0.24 | |||||
PB Ratio | 0.83 | |||||
Price-to-Tangible-Book | 0.85 | |||||
Price-to-Free-Cash-Flow | 3.29 | |||||
Price-to-Operating-Cash-Flow | 2.95 | |||||
EV-to-EBIT | 6.55 | |||||
EV-to-EBITDA | 5.56 | |||||
EV-to-Revenue | 0.35 | |||||
EV-to-FCF | 4.31 | |||||
Price-to-GF-Value | 0.53 | |||||
Price-to-Projected-FCF | 0.47 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.96 | |||||
Price-to-Graham-Number | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 1.06 | |||||
Earnings Yield (Greenblatt) % | 15.28 | |||||
FCF Yield % | 29.39 | |||||
Forward Rate of Return (Yacktman) % | 30.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chandra Bhagat Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,162.717 | ||
| EPS (TTM) (₹) | 4.04 | ||
| Beta | 0.3776 | ||
| 3-Year Sharpe Ratio | -0.73 | ||
| 3-Year Sortino Ratio | -0.95 | ||
| Volatility % | 54.05 | ||
| 14-Day RSI | 52.01 | ||
| 14-Day ATR (₹) | 1.460003 | ||
| 20-Day SMA (₹) | 35.813 | ||
| 12-1 Month Momentum % | -22.36 | ||
| 52-Week Range (₹) | 29.7 - 59 | ||
| Shares Outstanding (Mil) | 7.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chandra Bhagat Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chandra Bhagat Pharma Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chandra Bhagat Pharma Ltd Frequently Asked Questions
What is Chandra Bhagat Pharma Ltd(BOM:542934)'s stock price today?
The current price of BOM:542934 is ₹37.50. The 52 week high of BOM:542934 is ₹59.00 and 52 week low is ₹29.70.
When is next earnings date of Chandra Bhagat Pharma Ltd(BOM:542934)?
The next earnings date of Chandra Bhagat Pharma Ltd(BOM:542934) is .
Does Chandra Bhagat Pharma Ltd(BOM:542934) pay dividends? If so, how much?
Chandra Bhagat Pharma Ltd(BOM:542934) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Chandra Bhagat Pharma Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers